STOCK TITAN

Arturo Molina plans $1,097,115.60 PTGX (NASDAQ: PTGX) share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Arturo Molina has filed a notice of proposed sale under Rule 144 to sell 13,151 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $1,097,115.60 and an approximate sale date of 01/23/2026. The table shows 62,515,666 common shares outstanding as a baseline figure.

The shares to be sold were acquired as restricted stock from the issuer in several grants on 11/15/2025 and 01/15/2026. Over the past three months, Molina has already sold 2,712 common shares on 11/18/2025 for gross proceeds of $229,896.24 and 9,514 common shares on 01/20/2026 for gross proceeds of $784,702.35. By signing, the seller represents not knowing any undisclosed material adverse information about the issuer's operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many PTGX shares is Arturo Molina planning to sell under this Form 144?

Arturo Molina has filed to sell 13,151 shares of common stock. The filing lists these shares with an aggregate market value of $1,097,115.60 and an approximate sale date of 01/23/2026 on NASDAQ.

What is the aggregate market value of the PTGX shares to be sold?

The notice states that the 13,151 common shares to be sold have an aggregate market value of $1,097,115.60, based on the market price at the time of the Form 144 filing.

What PTGX trading venue is used for this planned Rule 144 sale?

The shares are expected to be sold on the NASDAQ. The broker named for the transaction is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

How many PTGX shares are shown as outstanding in this Form 144?

The securities information table lists 62,515,666 common shares as the number of shares outstanding. This figure provides a baseline context for the size of the planned sale.

What PTGX shares has Arturo Molina sold in the last three months?

Over the past three months, Arturo Molina sold 2,712 common shares on 11/18/2025 for gross proceeds of $229,896.24 and 9,514 common shares on 01/20/2026 for gross proceeds of $784,702.35.

How were the PTGX shares to be sold acquired by Arturo Molina?

The Form 144 shows the shares were acquired as restricted stock from the issuer. Acquisitions include grants on 11/15/2025 of 2,601 shares and on 01/15/2026 totaling several blocks such as 4,800, 5,100, and 650 shares, with payment listed as "Not Applicable".

What representation does the seller make in this PTGX Form 144 filing?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.

Protagonist Ther

NASDAQ:PTGX

PTGX Rankings

PTGX Latest News

PTGX Latest SEC Filings

PTGX Stock Data

5.30B
60.63M
1.03%
116.23%
11.01%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEWARK